Shadi Swaidani
- Immunology top 2%
- IL-33, ST2, and ILC Pathways 7
- Immune Cell Function and Interaction 6
- Immune Response and Inflammation 4
- Immune cells in cancer 4
- Internal Medicine top 5%
- Cancer Research top 10%
- Dermatology top 2%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
-
- Asthma and respiratory diseases 12
-
- Proteoglycans and glycosaminoglycans research 6
-
- Neonatal Respiratory Health Research 4
- Co-authors
- Mark AronicaXiaoxia LiCaini LiuKatarzyna BulekYi LuMuhammet F. GülenVincent HascallYoucun Qian
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (1 paper)Blood (5 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Shadi Swaidani
33 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 104
- Immunology 1.4k
- Internal Medicine 78
- Cancer Research 305
- Dermatology 176
- Oncology 451
Countries citing papers authored by Shadi Swaidani
This map shows the geographic impact of Shadi Swaidani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shadi Swaidani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shadi Swaidani more than expected).
Fields of papers citing papers by Shadi Swaidani
This network shows the impact of papers produced by Shadi Swaidani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shadi Swaidani. The network helps show where Shadi Swaidani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shadi Swaidani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 9 | |
| 3 | 2021 | 84 | |
| 4 | 2021 | 24 | |
| 5 | 2020 | 129 | |
| 6 | Pomalidomide in HHT: Results of a pilot study | 2019 | 1 |
| 7 | 2019 | 64 | |
| 8 | 2012 | 59 | |
| 9 | 2012 | 43 | |
| 10 | 2012 | 38 | |
| 11 | 2012 | 54 | |
| 12 | 2011 | 66 | |
| 13 | 2011 | 164 | |
| 14 | 2010 | 223 | |
| 15 | 2009 | 110 | |
| 16 | 2007 | 29 | |
| 17 | 2006 | 160 | |
| 18 | 2004 | 6 | |
| 19 | 2003 | 19 | |
| 20 | 2000 | 17 |
About Shadi Swaidani
Shadi Swaidani is a scholar working on Immunology, Internal Medicine and Physiology, having authored 35 papers that have together received 2.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (7 papers), Immune Cell Function and Interaction (6 papers), Proteoglycans and glycosaminoglycans research (6 papers), Neonatal Respiratory Health Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Response and Inflammation (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Immunology (1.4k citations), Internal Medicine (78 citations) and Cancer Research (305 citations). Shadi Swaidani has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Mark Aronica, Xiaoxia Li, Caini Liu, Katarzyna Bulek, Yi Lu, Muhammet F. Gülen, Vincent Hascall, Youcun Qian, Natalia V. Giltiay and Mark Lauer. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.